Functional Focus

• Discovery Research
• Development
• Commercial
• Corporate

Development

Caliber's expertise is deep in understanding what it takes to move compounds or biologically derived products from the discovery bench into development. We have conducted searches in Preclinical Development, Toxicology, Formulations and Analytical Chemistry. Additionally, we have demonstrated a track record of success in identifying key leaders in Translational Medicine, Clinical Research, Medical Affairs and Regulatory Affairs.

Clients

• Advanced Tissue Sciences, Inc.
• Albany Molecular Research, Inc.
• AlgoRx Pharmaceuticals, Inc. (now Anesiva)
• Algos Therapeutics, Inc. (now Endo)
• Alpha Therapeutic Corporation (now Grifols)
• ALZA Corporation (now J&J)
• American Type Culture Collection
• Amicus Therapeutics, Inc.
• Applied Immune Sciences, Inc. (now Sanofi-Aventis)
• Arena Pharmaceuticals, Inc.
• Armour Pharmaceutical Co. (now CSL Behring)
• Avanir Pharmaceuticals, Inc.
• BioChem Pharma, Inc.
• Cadence Pharmaceuticals, Inc.
• Celator Pharmaceuticals, Inc.
• Cephalon, Inc. (Now Teva Pharmaceuticals)
• Ceregene, Inc.
• CFY BioMedicals, Inc. (later renamed Perlan Therapeutics)
• CoCensys, Inc. (now Purdue)
• Coley Pharmaceutical Group, Inc. (now Pfizer)
• Conforma Therapeutics Corporation (now Biogen Idec)
• Connetics Corporation (now Stiefel)
• Coulter Pharmaceuticals, Inc. (now GSK)
• CpG Immuno Pharmaceuticals, Inc (Now Pfizer)
• Curagen Corporation (Now Celldex Therapeutics)
• Delsys, Inc. (now Elan)
• Dermik Laboratories, Inc. (now Sanofi-Aventis)
• Dura Pharmaceuticals, Inc. (now Elan)
• Enzon, Inc.
• Faulding, Inc. (now Hospira)
• GenStar Therapeutics Corporation (now VIA Pharmaceuticals)
• Genzyme Corporation
• IBAH, Inc. (now Omnicare)
• ICN Pharmaceuticals, Inc. (now Valeant Pharmaceuticals)
• Immunization Products, Ltd.
• Isis Pharmaceuticals, Inc.
• Koronis Pharmaceuticals, Inc.
• La Jolla Pharmaceutical Company
• Mallinckrodt Medical, Inc. (now Covidien)
• MedImmune, Inc.
• MedPointe, Inc. (now Meda)
• Molecular Insight Pharmaceuticals, Inc.
• Nanogen, Inc. (Now The Elitech Group)
• NeurogesX, Inc.
• Noramco, Inc. (part of Johnson & Johnson)
• Novartis
• NPS Pharmaceuticals, Inc.
• Onyx Pharmaceuticals, Inc.
• Pan Pacific Pharmaceuticals, Inc.
• Paratek Pharmaceuticals, Inc.
• PaxVax, Inc.
• PharmaCyclics, Inc.
• PharmaKinetics Laboratories, Inc.
• Rhone-Poulenc Rorer, Inc. (now Sanofi-Aventis)
• Ross Products, Inc. (now Abbott Nutrition)
• RPR-Gencell
• Salmedix, Inc. (now Teva Pharmaceuticals)
• Selective Genetics, Inc.
• Sepracor, Inc. (Now Sunovion)
• SGX Pharmaceuticals, Inc. (now Pfizer)
• SkinMedica, Inc.
• SmithKline Beecham Corporation (now GlaxoSmithKline)
• Sonus Pharmaceuticals (now OncoGenex Pharmaceuticals)
• Sprout Pharmaceuticals
• SRI International, Inc.
• Suntory Pharmaceutical Research Laboratories, LLC.
• Verion, Inc.
• Vical, Inc.
• ViroPharma, Inc.
• Zeneca, Inc. (now AstraZeneca)

Koronis Pharmaceuticals, Inc.

Koronis Pharmaceuticals, Inc. is a privately held biotechnology company developing anti-viral therapeutics based on a novel mechanism, Viral Decay Acceleration (VDA). The Company's lead product candidate is KP-1461 for the treatment of human immunodeficiency virus (HIV). The Company also has products in development for the treatment of hepatitis C and RSV.

Search Projects

• Chief Executive Officer
• Vice President, Clinical Research and Chief Medical Officer